...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: ASCO 2019 coming up May 31 to June 4
5
Mar 30, 2019 06:07AM
5
Mar 31, 2019 08:05AM
2
Apr 01, 2019 02:39PM
1
Apr 01, 2019 05:52PM
3
Apr 01, 2019 05:58PM
2
Apr 01, 2019 08:25PM
8
Apr 08, 2019 11:46AM
2
Apr 09, 2019 11:36AM

Yes, a poor cash period.
They need to preserve whatever cash they have as I see it.

Looking at the Jan 31st Financial Statement, they are low in cash.  Could be several reasons why they aren't attending those conferences which might include limiting discretionary expenses in the short term until their cash position changes.

Share
New Message
Please login to post a reply